UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC trimmed its stake in shares of AvePoint, Inc. (NASDAQ:AVPT – Free Report) by 10.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 232,685 shares of the company’s stock after selling 26,004 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in AvePoint were worth $2,739,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently modified their holdings of the company. SG Americas Securities LLC lifted its position in shares of AvePoint by 43.2% during the second quarter. SG Americas Securities LLC now owns 23,949 shares of the company’s stock worth $250,000 after purchasing an additional 7,222 shares during the last quarter. Calamos Advisors LLC grew its position in shares of AvePoint by 349.9% in the 2nd quarter. Calamos Advisors LLC now owns 204,359 shares of the company’s stock worth $2,129,000 after acquiring an additional 158,940 shares in the last quarter. Principal Financial Group Inc. increased its holdings in shares of AvePoint by 7.5% in the 2nd quarter. Principal Financial Group Inc. now owns 86,724 shares of the company’s stock valued at $904,000 after acquiring an additional 6,027 shares during the last quarter. nVerses Capital LLC acquired a new stake in shares of AvePoint during the 2nd quarter valued at approximately $173,000. Finally, Acadian Asset Management LLC acquired a new stake in shares of AvePoint during the 2nd quarter valued at approximately $2,250,000. Institutional investors own 44.49% of the company’s stock.
Insider Buying and Selling at AvePoint
In related news, major shareholder Zhijian Lu sold 10,000 shares of the stock in a transaction dated Monday, September 16th. The shares were sold at an average price of $11.91, for a total value of $119,100.00. Following the completion of the transaction, the insider now owns 18,430,673 shares in the company, valued at $219,509,315.43. This represents a 0.05 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CFO James Caci sold 20,215 shares of the business’s stock in a transaction dated Wednesday, November 20th. The stock was sold at an average price of $17.12, for a total transaction of $346,080.80. Following the sale, the chief financial officer now owns 591,890 shares in the company, valued at $10,133,156.80. This trade represents a 3.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 130,215 shares of company stock worth $1,795,881. 27.78% of the stock is owned by company insiders.
AvePoint Stock Down 1.1 %
Analysts Set New Price Targets
Separately, The Goldman Sachs Group boosted their target price on shares of AvePoint from $7.50 to $15.00 and gave the company a “neutral” rating in a research note on Tuesday, November 12th. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $13.20.
Read Our Latest Analysis on AVPT
About AvePoint
AvePoint, Inc provides cloud-native data management software platform in North America, Europe, Middle East, Africa, and Asia Pacific. It also offers software-as-a-service solutions and productivity applications. The company offers modularity and cloud services architecture to address critical challenges and the management of data to organizations that leverage third-party cloud vendors, including Microsoft, Salesforce, Google, AWS, Box, DropBox, and others; license and support; and maintenance services.
Read More
- Five stocks we like better than AvePoint
- Differences Between Momentum Investing and Long Term Investing
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Election Stocks: How Elections Affect the Stock Market
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What is a Low P/E Ratio and What Does it Tell Investors?
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Want to see what other hedge funds are holding AVPT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AvePoint, Inc. (NASDAQ:AVPT – Free Report).
Receive News & Ratings for AvePoint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AvePoint and related companies with MarketBeat.com's FREE daily email newsletter.